Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report) shares fell 1.9% during trading on Friday . The company traded as low as GBX 26 ($0.33) and last traded at GBX 26.50 ($0.33). 49,264 shares traded hands during trading, a decline of 85% from the average session volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.34).
Mereo BioPharma Group plc (MPH.L) Stock Performance
The company has a quick ratio of 2.92, a current ratio of 2.98 and a debt-to-equity ratio of 164.26. The company has a market cap of £89.76 million and a price-to-earnings ratio of -0.21. The stock has a 50 day simple moving average of GBX 26.50 and a 200 day simple moving average of GBX 26.50.
Mereo BioPharma Group plc (MPH.L) Company Profile
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Featured Articles
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Want to Profit on the Downtrend? Downtrends, Explained.
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Transportation Stocks Investing
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
